Site-directed mutagenesis of recombinant human beta 2-glycoprotein I. Effect of phospholipid binding and anticardiolipin antibody activity.
Sheng
Y
Y
Department of Immunology, Allergy, and Infectious Disease, University of New South Wales, St. George Hospital, Kogarah, Australia.
Krilis
S A
SA
Sali
A
A
D017153:Antibodies, Anticardiolipin / Q000276:immunology*; D001665:Binding Sites; D004797:Enzyme-Linked Immunosorbent Assay; D006023:Glycoproteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008239:Lysine; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D010743:Phospholipids / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D053482:beta 2-Glycoprotein I
D017153:Antibodies, Anticardiolipin; D006023:Glycoproteins; D010743:Phospholipids; D011994:Recombinant Proteins; D053482:beta 2-Glycoprotein I; D008239:Lysine